Company Filing History:
Years Active: 2003
Title: Innovations of Mohamed A Khan in Cell Death Inhibition
Introduction
Mohamed A Khan is an accomplished inventor based in Sunnyvale, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cell death inhibition. His innovative work has the potential to impact various medical conditions associated with cell death.
Latest Patents
Khan holds a patent for "Bis-benzimidazole compounds and analogs thereof for inhibiting cell death." This patent describes compounds, pharmaceutical compositions, and methods that are effective in inhibiting cell death, especially apoptotic cell death. The compositions can be utilized for the prevention and treatment of injuries related to cell death, including ischemia resulting from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. He has 1 patent to his name.
Career Highlights
Khan is currently associated with Elan Pharma International Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.
Collaborations
Some of his notable coworkers include Catherine M Bitler and Paul L Wood, who have collaborated with him on various projects.
Conclusion
Mohamed A Khan's contributions to the field of cell death inhibition through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work has the potential to lead to advancements in the treatment of critical medical conditions.